Schönenberger, Helmut and Adam, A. (1964) The carcinostatic effects of amino alkylating compounds. I. Cytostatic compounds. Arzneimittel-Forschung = Drug research 14 (10), p. 1168.
Full text not available from this repository.
The cystostatic effects were established of 5 new classes of compds., e.g. (Me2N)2CH2, (EtSCH2NMeCH2)2, Me2NCH2S2CNMe2, N,N'-bis(ethylthiomethyl)imidazolidine, and 1,4,6,9-tetraazatricyclo[22.214.171.124.4.9]dodecane. The tests were carried out on the Ehrlich ascites tumor in mice. The compds. probably act via alpha -amino alkylation of biol. important substrates. With the compds. 70-90% of the animals survived for >=60 days while the controls had a mean life of 15 days.
|Additional information (public):||CAN 62:39497 68 Pharmacodynamics 5751-48-4 (Derived from data in the 7th Collective Formula Index (1962-1966); 51-46-7 (1,3,6,8-Tetraazatricyclo[126.96.36.199,8]dodecane); 51-69-4 (Imidazolidine, 1,3-bis[(ethylthio)methyl]-); 51-76-3 (Ethylenediamine, N,N'-bis[(ethylthio)methyl]-N,N'-dimethyl-); 51-80-9 (Methanediamine, N,N,N',N'-tetramethyl-); 51-82-1 (Methanethiol, (dimethylamino)-, dimethyldithiocarbamate) (carcinoma inhibition by)|
|Institutions:||Chemistry and Pharmacy > Institute of Pharmacy > Retired Professors > Prof. Schönenberger|
|Keywords:||Carcinoma (inhibitors of, aminoalkylating compds. as)|
|Subjects:||500 Science > 540 Chemistry & allied sciences|
|Refereed:||Yes, this version has been refereed|
|Created at the University of Regensburg:||Unknown|
|Deposited On:||19 Nov 2010 09:56|
|Last Modified:||19 Nov 2010 09:56|